Develops and commercializes non-invasive medical devices based on proprietary applications of near-infrared spectroscopy (NIRS), focusing on products that aid in the diagnosis and treatment of urological diseases and related conditions, including urinary incontinence and lower urinary tract symptoms, benign prostatic hyperplasia, prostate cancer, erectile dysfunction and intra-abdominal hypertension, and abdominal compartment syndrome.